DPW
XBI icon

DiNuzzo Private Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

DiNuzzo Private Wealth’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-200
Closed -$16.2K – 1408
2025
Q1 		$16.2K Buy
+200
New +$17.9K ﹤0.01% 196

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

DiNuzzo Private Wealth's XBI Position: Q2 2025 in Review

DiNuzzo Private Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 200 shares — an estimated $16.2K sold.

DiNuzzo Private Wealth first reported a position in XBI in Q1 2025 and held it in 1 quarter. The position peaked at $16.2K in Q1 2025. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

  • DiNuzzo Private Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
  • DiNuzzo Private Wealth sold 200 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $16.2K.
  • DiNuzzo Private Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and held it in 1 quarter.
  • DiNuzzo Private Wealth's State Street SPDR S&P Biotech ETF position peaked at $16.2K in Q1 2025.
  • 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2025, filed 17 Jul 2025.